tiprankstipranks
Trending News
More News >

Shanghai Haohai Biological Technology Schedules Board Meeting for Annual Results

Story Highlights
Shanghai Haohai Biological Technology Schedules Board Meeting for Annual Results

Confident Investing Starts Here:

An update from Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) is now available.

Shanghai Haohai Biological Technology Co., Ltd. has scheduled a board meeting for March 21, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation for a final dividend, which could impact the company’s financial strategy and shareholder returns.

More about Shanghai Haohai Biological Technology Co., Ltd. Class H

Shanghai Haohai Biological Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the biotechnology sector, focusing on the development and production of biological products.

YTD Price Performance: -0.56%

Average Trading Volume: 254,896

Technical Sentiment Consensus Rating: Buy

Current Market Cap: HK$13.49B

For detailed information about 6826 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App